PVALB and Alzheimer disease: Supporting this hypothesis, Verret et al. [22] reported a reduction in γ-oscillations in human APP mice and AD patients, linked to decreased levels of the interneuron-specific voltage-gated sodium channel subunit Nav1.1 in parvalbumin-expressing interneuron.